Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06167655 · ClinicalTrials.gov registry record · NA
A Pivotal Study Evaluating Safety AND Efficacy OF THE Shiratronics Migraine Therapy System
A NA study of Headache Migraine Chronic, sponsored by ShiraTronics.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 20
- Study locations
NCT06167655 is a NA study of Headache Migraine Chronic that is actively recruiting participants, run by ShiraTronics. The registered enrollment target is 250 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT06167655, a NA study of Headache Migraine Chronic, is actively recruiting participants, sponsored by ShiraTronics.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.
Conditions Studied
Interventions
- DEVICE Neurostimulator
Study Locations (20)
Minnesota
- iSpine Clinics - Chaska
- University of Minnesota - Minneapolis
- Mayo Clinic Rochester - Rochester
New York
- Dent Neurologic Institute - Amherst
- Northwell Health Physician Partners - New York
- Montefiore Health - New York
California
- UC San Diego Health - La Jolla
- Neurovations - Napa
North Carolina
- Queen City Clinical Research - Charlotte
- The Center for Clinical Research - Winston-Salem
Pennsylvania
- Argires Marotti Neurological Associates - Lancaster
- Jefferson Headache Center - Philadelphia
Arizona
- Mayo Clinic Arizona - Scottsdale
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Colorado
- Barolat Neuroscience - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-05-29 |
| Est. Completion | 2026-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06167655
The ClinicalTrials.gov registry entry for NCT06167655 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ShiraTronics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Headache Migraine Chronic appearing as the primary indexed condition, and to 1 intervention - of which Neurostimulator is the first listed.
NCT06167655 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Minnesota, New York, California.
Frequently Asked Questions
What is clinical trial NCT06167655 about?
NCT06167655 is a clinical study titled "A Pivotal Study Evaluating Safety AND Efficacy OF THE Shiratronics Migraine Therapy System". Prospective, multi-center, double blind, randomized, sham-controlled study to evaluate neuromodulation in patient with chronic migraine. The study hypothesis to be tested is the mean reduction in mean monthly headache days between patients in treatment versus sham.
What is the current status of trial NCT06167655?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-05-29. Estimated completion is 2026-08-30.
What conditions does trial NCT06167655 study?
This clinical trial studies the following conditions: Headache Migraine Chronic.
What interventions are being tested in trial NCT06167655?
The interventions under investigation include: Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT06167655?
This trial is sponsored by ShiraTronics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06167655 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.